This study demonstrated that TRF2 expression can be pharmacologically modulated, and that our screening assay is a reliable method for the selection of drugs capable of modulating TRF2 expression levels, with potential anti-cancer and anti-aging properties. The gene discussed is TERF2; the disease is cancer.